News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
Cybin Inc.
Mindset Pharma
Mindset Pharma Provides Strategic Intellectual Property License to Cybin
Mindset Pharma
Cybin Inc.
Psyched Wellness Announces Successful Pilot Run, Final Flavour Profile for Calm and Shipping Pre-Orders in October
Psyched Wellness
Delix Therapeutics Expands World-Class Team with First Head of R&D
Delix Therapeutics
Wellbeing Subsidiary KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future
Wellbeing Digital Sciences
Core One Labs Signs Letter of Intent with GMP Manufacturing Partner for Production of Proprietary Psychedelic Compounds
Core One Labs Inc.
Clearmind Announces Notice of Proposed Stock Consolidation
Clearmind Medicine
Psychedelic Weekly Headlines | September 23
Psyence Group
Numinus
Small Pharma
Biomind Labs
Mind Medicine (MindMed)
Mydecine Innovations Group Announces Closing Under Share Subscription Agreement And Welcomes New Cfo
Mydecine Innovations Group
Wellbeing Digital to Participate in the Microdose Psychedelic Capital Conference
Wellbeing Digital Sciences
Nirvana Life Sciences Inc. Deuterates 7-Hydroxymitragynine to Create D7-h, an Analogue that May Improve Research and Formulations using Kratom Derivatives
Nirvana Life Sciences
BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials
MindBio Therapeutics
Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome
Clearmind Medicine
Psyence Group Completes Export of Psilocybin Mushrooms to Canada
Psyence Group
Filament Health
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.